Navigation

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban [ID437]

Rivaroxaban for the treatment and secondary prevention of venous thromboembolism

Status: History
Expected date of issue: July 2012
Referral date: January 2011
Process: STA
Notes:

Scoped within Batch 15

Topic area:
 

NICE project team

Executive Lead: Gillian Leng
Technical Lead: Kumar Perampaladas
Communications manager: Phil Ranson
Project manager: Bijal Joshi
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 4 November 2011
1st appraisal committee meeting: 15 February 2012
2nd appraisal committee meeting 17 April 2012
Top


 

Consultees and commentators

Please see the final matrix for a full list of consultees and commentators.

Top


 

Key documents

This page was last updated: 06 December 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.